Skip to content

Effect of Polyherbal Ayurvedic formulation (Obegar G150) in management of Obesity.

A Pilot Clinical Study to evaluate Efficacy and Safety of Polyherbal formulation (Obegar G150) in management of Obesity. - NIL

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/11/076466
Enrollment
30
Registered
2024-11-08
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E669- Obesity, unspecified

Interventions

None listed

Sponsors

Sudhatatva Pharmacy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Obese Patients above 18 years to 60 Years. 2.Both Male and female sex included in trial. 3.Patients with Body mass index(BMI)more than 25kg/m2 4.Patients having signs and symptoms of Sthaulya(Obesity) as Per ayurveda and modern texts

Exclusion criteria

Exclusion criteria: 1)Patient having any systemic disorders which require long term drug treatment 2)Patients with Body Mass Index (BMI) more than 40kg/m2 3)Patients with complaint of Cardiovascular diseases 4)Pregnant women, ascites, portal hypertension 5)Unable to provide written informed consent.

Design outcomes

Primary

MeasureTime frame
Change in BMI and Blood lipid levels.Timepoint: TIME POINTS-14TH-28TH DAY FOLLOW UP WILL BE TAAKEN FOR Subjective Parameters and clinical assessment through body fat monitor will be assessed at baseline, 14th, and 28th day. Laboratory Parameters (Lipid Profile) will be done at Screening/baseline and after completion of the study period i.e.28 th days.

Secondary

MeasureTime frame
Change in Visceral fat% and other clinical sign symptoms of ObesityTimepoint: TIME POINTS-14TH-28TH DAY FOLLOW UP WILL BE TAKEN FOR Subjective Parameters and clinical assessment through body fat monitor will be assessed at baseline, 14th, and 28th day. Laboratory Parameters (Lipid Profile) will be done at Screening/baseline and after completion of the study period i.e.28 th days.

Countries

India

Contacts

Public ContactDr Santosh Kamble

Dr D.Y.Patil College Of Ayurved and Research Centre,Pimpri,Pune-18.Dr.D.Y.Patil Vidyapeeth,Pune

santosh.kamble@dpu.edu.in8010874446

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026